InvestorsHub Logo
Followers 3
Posts 288
Boards Moderated 0
Alias Born 12/21/2022

Re: ATLcitizen post# 3230

Thursday, 04/06/2023 1:31:41 PM

Thursday, April 06, 2023 1:31:41 PM

Post# of 3283
Yes, Poziotinib works. But toxicity issues are real. For any company who is thinking buy it, you need to consider a necessary phase 3 trial and competition. I can see a few drugs in clinical trials that can potentially work as Pozi but less toxic. Will be interesting to see Pyrotinib data.